Skip to main content
Premium Trial:

Request an Annual Quote

New Genome Institute Opens in Minsk

NEW YORK (GenomeWeb News) – The National Academy of Sciences of Belarus (NASB) this week launched a new institute to provide genetic testing and research services in Minsk.

The new National Center of Genome Biotechnology will provide services for determining the presence of genetically modified ingredients in food raw materials and agricultural products, to identify DNA markers for certification of crop varieties, and to identify the genes responsible for valuable characteristics and diseases in animals and individual human traits.

According to the state-run Belarusian Telegraph Agency, the center opened yesterday at the Institute of Genetics and Cytology at the NASB. It will support government agencies including the Ministry of Agriculture and Food, the Sport and Tourism Ministry, and the Ministry of Natural Resources and Environment.

The National Center of Genome Biotechnology, which has received certification for ISO quality management standards, will reach its full testing capabilities in about a year, when it will provide at least 6,944 tests per year.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in EJHG find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.